Generation of domestic transgenic cloned kittens using lentivirus vectors

Martha C. Gómez, Charles Earle Pope, Robert H. Kutner, David M. Ricks, Leslie A Lyons, Mark T. Ruhe, Cherie Dumas, Justine Lyons, Betsy L. Dresser, Jakob Reiser

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The efficient use of somatic cell nuclear transfer (SCNT), in conjunction with genetic modification of donor cells provides a general means to add or inactivate genes in mammals. This strategy has substantially improved the efficacy of producing genetically identical animals carrying mutant genes corresponding to specific human disorders. Lentiviral (LV) vectors have been shown to be well suited for introducing transgenes into cells to be used as donor nuclei for SCNT. In the present study, we established an LV vector-based transgene delivery approach for producing live transgenic domestic cats by SCNT. We have demonstrated that cat fetal fibroblasts can be transduced with EGFP-encoding LV vectors bearing various promoters including the human cytomegalovirus immediate early (hCMV-IE) promoter, the human translation elongation factor 1α (hEF-1α) promoter and the human ubiquitin C (hUbC) promoter. Among the promoters tested, embryos reconstructed with donor cells transduced with a LV-vector bearing the hUbC promoter displayed sustained transgene expression at the blastocyst stage while embryos reconstructed with LV vector-transduced cells containing hCMV-IE-EGFP or hEF-1α-EGFP cassettes did not. After transfer of 291 transgenic cloned embryos into the oviducts of eight recipient domestic cats (mean = 36.5 ± 10.1), three (37.5%) were diagnosed to be pregnant, and a total of six embryos (2.1%) implanted. One live male offspring was delivered by Cesarean section on day 64 of gestation, and two kittens were born dead after premature delivery on day 55. In summary, we report the birth of transgenic cloned kittens produced by LV vector-mediated transduction of donor cells and confirm that cloned kittens express the EGFP reporter transgene in all body tissues.

Original languageEnglish (US)
Pages (from-to)167-175
Number of pages9
JournalCloning and Stem Cells
Volume11
Issue number1
DOIs
StatePublished - Mar 1 2009

Fingerprint

Lentivirus
Transgenes
Ubiquitin C
Embryonic Structures
Peptide Elongation Factor 1
Cats
Ubiquitin
Cytomegalovirus
Oviducts
Blastocyst
Cell Nucleus
Cesarean Section
Genes
Mammals
Fibroblasts
Parturition
Pregnancy

ASJC Scopus subject areas

  • Biotechnology
  • Developmental Biology

Cite this

Gómez, M. C., Pope, C. E., Kutner, R. H., Ricks, D. M., Lyons, L. A., Ruhe, M. T., ... Reiser, J. (2009). Generation of domestic transgenic cloned kittens using lentivirus vectors. Cloning and Stem Cells, 11(1), 167-175. https://doi.org/10.1089/clo.2008.0054

Generation of domestic transgenic cloned kittens using lentivirus vectors. / Gómez, Martha C.; Pope, Charles Earle; Kutner, Robert H.; Ricks, David M.; Lyons, Leslie A; Ruhe, Mark T.; Dumas, Cherie; Lyons, Justine; Dresser, Betsy L.; Reiser, Jakob.

In: Cloning and Stem Cells, Vol. 11, No. 1, 01.03.2009, p. 167-175.

Research output: Contribution to journalArticle

Gómez, MC, Pope, CE, Kutner, RH, Ricks, DM, Lyons, LA, Ruhe, MT, Dumas, C, Lyons, J, Dresser, BL & Reiser, J 2009, 'Generation of domestic transgenic cloned kittens using lentivirus vectors', Cloning and Stem Cells, vol. 11, no. 1, pp. 167-175. https://doi.org/10.1089/clo.2008.0054
Gómez, Martha C. ; Pope, Charles Earle ; Kutner, Robert H. ; Ricks, David M. ; Lyons, Leslie A ; Ruhe, Mark T. ; Dumas, Cherie ; Lyons, Justine ; Dresser, Betsy L. ; Reiser, Jakob. / Generation of domestic transgenic cloned kittens using lentivirus vectors. In: Cloning and Stem Cells. 2009 ; Vol. 11, No. 1. pp. 167-175.
@article{742fbf60d07040c787c26f5e1caaff47,
title = "Generation of domestic transgenic cloned kittens using lentivirus vectors",
abstract = "The efficient use of somatic cell nuclear transfer (SCNT), in conjunction with genetic modification of donor cells provides a general means to add or inactivate genes in mammals. This strategy has substantially improved the efficacy of producing genetically identical animals carrying mutant genes corresponding to specific human disorders. Lentiviral (LV) vectors have been shown to be well suited for introducing transgenes into cells to be used as donor nuclei for SCNT. In the present study, we established an LV vector-based transgene delivery approach for producing live transgenic domestic cats by SCNT. We have demonstrated that cat fetal fibroblasts can be transduced with EGFP-encoding LV vectors bearing various promoters including the human cytomegalovirus immediate early (hCMV-IE) promoter, the human translation elongation factor 1α (hEF-1α) promoter and the human ubiquitin C (hUbC) promoter. Among the promoters tested, embryos reconstructed with donor cells transduced with a LV-vector bearing the hUbC promoter displayed sustained transgene expression at the blastocyst stage while embryos reconstructed with LV vector-transduced cells containing hCMV-IE-EGFP or hEF-1α-EGFP cassettes did not. After transfer of 291 transgenic cloned embryos into the oviducts of eight recipient domestic cats (mean = 36.5 ± 10.1), three (37.5{\%}) were diagnosed to be pregnant, and a total of six embryos (2.1{\%}) implanted. One live male offspring was delivered by Cesarean section on day 64 of gestation, and two kittens were born dead after premature delivery on day 55. In summary, we report the birth of transgenic cloned kittens produced by LV vector-mediated transduction of donor cells and confirm that cloned kittens express the EGFP reporter transgene in all body tissues.",
author = "G{\'o}mez, {Martha C.} and Pope, {Charles Earle} and Kutner, {Robert H.} and Ricks, {David M.} and Lyons, {Leslie A} and Ruhe, {Mark T.} and Cherie Dumas and Justine Lyons and Dresser, {Betsy L.} and Jakob Reiser",
year = "2009",
month = "3",
day = "1",
doi = "10.1089/clo.2008.0054",
language = "English (US)",
volume = "11",
pages = "167--175",
journal = "Cellular Reprogramming",
issn = "2152-4971",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Generation of domestic transgenic cloned kittens using lentivirus vectors

AU - Gómez, Martha C.

AU - Pope, Charles Earle

AU - Kutner, Robert H.

AU - Ricks, David M.

AU - Lyons, Leslie A

AU - Ruhe, Mark T.

AU - Dumas, Cherie

AU - Lyons, Justine

AU - Dresser, Betsy L.

AU - Reiser, Jakob

PY - 2009/3/1

Y1 - 2009/3/1

N2 - The efficient use of somatic cell nuclear transfer (SCNT), in conjunction with genetic modification of donor cells provides a general means to add or inactivate genes in mammals. This strategy has substantially improved the efficacy of producing genetically identical animals carrying mutant genes corresponding to specific human disorders. Lentiviral (LV) vectors have been shown to be well suited for introducing transgenes into cells to be used as donor nuclei for SCNT. In the present study, we established an LV vector-based transgene delivery approach for producing live transgenic domestic cats by SCNT. We have demonstrated that cat fetal fibroblasts can be transduced with EGFP-encoding LV vectors bearing various promoters including the human cytomegalovirus immediate early (hCMV-IE) promoter, the human translation elongation factor 1α (hEF-1α) promoter and the human ubiquitin C (hUbC) promoter. Among the promoters tested, embryos reconstructed with donor cells transduced with a LV-vector bearing the hUbC promoter displayed sustained transgene expression at the blastocyst stage while embryos reconstructed with LV vector-transduced cells containing hCMV-IE-EGFP or hEF-1α-EGFP cassettes did not. After transfer of 291 transgenic cloned embryos into the oviducts of eight recipient domestic cats (mean = 36.5 ± 10.1), three (37.5%) were diagnosed to be pregnant, and a total of six embryos (2.1%) implanted. One live male offspring was delivered by Cesarean section on day 64 of gestation, and two kittens were born dead after premature delivery on day 55. In summary, we report the birth of transgenic cloned kittens produced by LV vector-mediated transduction of donor cells and confirm that cloned kittens express the EGFP reporter transgene in all body tissues.

AB - The efficient use of somatic cell nuclear transfer (SCNT), in conjunction with genetic modification of donor cells provides a general means to add or inactivate genes in mammals. This strategy has substantially improved the efficacy of producing genetically identical animals carrying mutant genes corresponding to specific human disorders. Lentiviral (LV) vectors have been shown to be well suited for introducing transgenes into cells to be used as donor nuclei for SCNT. In the present study, we established an LV vector-based transgene delivery approach for producing live transgenic domestic cats by SCNT. We have demonstrated that cat fetal fibroblasts can be transduced with EGFP-encoding LV vectors bearing various promoters including the human cytomegalovirus immediate early (hCMV-IE) promoter, the human translation elongation factor 1α (hEF-1α) promoter and the human ubiquitin C (hUbC) promoter. Among the promoters tested, embryos reconstructed with donor cells transduced with a LV-vector bearing the hUbC promoter displayed sustained transgene expression at the blastocyst stage while embryos reconstructed with LV vector-transduced cells containing hCMV-IE-EGFP or hEF-1α-EGFP cassettes did not. After transfer of 291 transgenic cloned embryos into the oviducts of eight recipient domestic cats (mean = 36.5 ± 10.1), three (37.5%) were diagnosed to be pregnant, and a total of six embryos (2.1%) implanted. One live male offspring was delivered by Cesarean section on day 64 of gestation, and two kittens were born dead after premature delivery on day 55. In summary, we report the birth of transgenic cloned kittens produced by LV vector-mediated transduction of donor cells and confirm that cloned kittens express the EGFP reporter transgene in all body tissues.

UR - http://www.scopus.com/inward/record.url?scp=62349128060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62349128060&partnerID=8YFLogxK

U2 - 10.1089/clo.2008.0054

DO - 10.1089/clo.2008.0054

M3 - Article

C2 - 19203232

AN - SCOPUS:62349128060

VL - 11

SP - 167

EP - 175

JO - Cellular Reprogramming

JF - Cellular Reprogramming

SN - 2152-4971

IS - 1

ER -